These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1369122)
81. Advances in understanding the pharmacological properties of antisense oligonucleotides. Crooke ST Adv Pharmacol; 1997; 40():1-49. PubMed ID: 9217922 [No Abstract] [Full Text] [Related]
82. Regulatory concerns for the chemistry, manufacturing, and controls of oligonucleotide therapeutics for use in clinical studies. Kambhampati RV; Chiu YY; Chen CW; Blumenstein JJ Antisense Res Dev; 1993; 3(4):405-10. PubMed ID: 8155982 [TBL] [Abstract][Full Text] [Related]
83. Bioanalysis considerations on the pharmacokinetic evaluation of antisense therapeutics. Norris DA; Post N; Yu RZ; Greenlee S; Wang Y Bioanalysis; 2019 Nov; 11(21):1909-1912. PubMed ID: 31648523 [No Abstract] [Full Text] [Related]